|Intra Cellular Therapies Inc -- USA Stock|| |
USD 14.9 0.34 2.23%
Sr. VP, General Counsel and Secretary
Mr. Michael I. Halstead is Senior Vice President, General Counsel, Secretary of IntraCellular Therapies, Inc. From July 2005 until December 2013, Mr. Halstead served in a number of leadership positions at Warner Chilcott plc. Most recently he was Senior Vice President, Corporationrationrate Development at Warner Chilcott where he directed the companys corporate development, legal and human resources functions. Prior to that, Mr. Halstead was an attorney at the firm of Davis Polk Wardwell
Age: 43 SVP Since 2014
212 923-3344 www.intracellulartherapies.com
Halstead received his bachelor?s degree from Boston University and his Juris Doctor degree from Villanova University School of Law.
The company has return on total asset (ROA)
of (13.99) %
which means that it has lost $13.99 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (26.45) %
meaning that it created substantial loss on money invested by shareholders.
IntraCellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system . Intra Cellular Therapies Inc (ITCI) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 37 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.